Vetoquinol SA (0O1O.L)

EUR 73.8

(0.27%)

Revenue Summary of Vetoquinol SA

  • Vetoquinol SA's latest annual revenue in 2023 was 529.27 Million EUR , down -1.94% from previous year.
  • Vetoquinol SA's latest quarterly revenue in 2024 Q2 was 264.44 Million EUR , down 0.0% from previous quarter.
  • Vetoquinol SA reported a annual revenue of 539.77 Million EUR in annual revenue 2022, up 3.55% from previous year.
  • Vetoquinol SA reported a annual revenue of 521.27 Million EUR in annual revenue 2021, up 21.94% from previous year.
  • Vetoquinol SA reported a quarterly revenue of 256.24 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • Vetoquinol SA reported a quarterly revenue of 273.02 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of Vetoquinol SA (2023 - 2005)

Historical Annual Revenue of Vetoquinol SA (2023 - 2005)

Year Revenue Revenue Growth
2023 529.27 Million EUR -1.94%
2022 539.77 Million EUR 3.55%
2021 521.27 Million EUR 21.94%
2020 427.46 Million EUR 7.95%
2019 395.99 Million EUR 7.62%
2018 367.94 Million EUR 4.48%
2017 352.17 Million EUR 0.52%
2016 350.35 Million EUR 2.26%
2015 342.61 Million EUR 8.66%
2014 315.29 Million EUR 5.2%
2013 299.72 Million EUR 0.48%
2012 298.29 Million EUR 4.98%
2011 284.13 Million EUR 0.74%
2010 282.04 Million EUR 9.72%
2009 257.05 Million EUR 9.67%
2008 234.39 Million EUR 0.44%
2007 233.36 Million EUR 10.29%
2006 211.59 Million EUR 7.62%
2005 196.61 Million EUR 0.0%

Peer Revenue Comparison of Vetoquinol SA

Name Revenue Revenue Difference
Boiron SA 493.24 Million EUR -7.303%
Laboratorios Farmaceuticos Rovi, S.A. 829.5 Million EUR 36.195%
Valneva SE 153.71 Million EUR -244.326%
AB Science S.A. 970 Thousand EUR -54464.021%
Nanobiotix S.A. 30.05 Million EUR -1660.832%
PHAXIAM Therapeutics S.A. 1.32 Million EUR -39814.857%
Vivoryon Therapeutics N.V. -3.62 Million EUR 14720.746%
BioSenic S.A. 543 Thousand EUR -97371.639%
ABIVAX Société Anonyme 4.62 Million EUR -11353.603%
Formycon AG 77.69 Million EUR -581.208%